{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T10:58:07Z","timestamp":1740135487682,"version":"3.37.3"},"reference-count":14,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T00:00:00Z","timestamp":1615334400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Psychiatry"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Poisoning and deaths by organo-phosphorous (OP) compounds are one of the major causes of death in developing and poor countries, and a common admission in the emergency ward and the ICU. OP compounds act by irreversibly binding to pseudocholinesterase enzyme and hence prolong the apnea in patients being given suxamethonium. We present a unusual case of OP poisoning (OPP) in which prolonged apnea ensued in a patient of severe depression following MECT (modified electroconvulsive therapy) in which suxamethonium was used as muscle relaxant, in whom we were cautious of the side-effect of prior organophosphorus poisoning. Since the cases of OPP are very high worldwide, a thorough knowledge of the interaction of the action of the drug and the receptors on which it acts takes pride of place. This article highlights the nuances in the field of psychiatry and anaesthesia in diagnosis and management of prolonged apnea after ECT.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Case presentation<\/jats:title>\n                <jats:p>A 53\/F patient consumed OP 38\u2009days prior to MECT. Since existing literature recommend a delay of 4\u2009weeks and a subminimal dose of suxamethonium to prevent prolonged apnea, both these points were taken into consideration. Despite 38\u2009days post exposure to OP, and a dose of succinylcholine of &lt;\u20090.3\u2009mg\/kg, the patient remained apneic for 3\u2009h. Suxamethionum apnea was managed with elective ventilation. After recovery, patient had no residual effect. Subsequently her pseudocholinesterase levels were done which were found to be very low.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This case is being presented to emphasize that behaviour of post synaptic receptors cannot be relied upon after OP poisoning and pseudocholinesterase levels needs to be mandatorily checked, irrespective of duration post-exposure. In strong suspects dibucaine number and fluoride number also needs to be estimated.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12888-021-03150-0","type":"journal-article","created":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:03:30Z","timestamp":1615381410000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prolonged apnea after ECT in organophosphorus poisoning \u2013 the need to redefine norms"],"prefix":"10.1186","volume":"21","author":[{"given":"Shibu","family":"Sasidharan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5956-874X","authenticated-orcid":false,"given":"Harpreet Singh","family":"Dhillon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,3,10]]},"reference":[{"key":"3150_CR1","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1097\/00000542-200311000-00006","volume":"99","author":"M Naguib","year":"2003","unstructured":"Naguib M, Samarkandi A, Riad W, Alharby SW. The optimal dose of succinylcholine revisited. Anesthesiology. 2003;99:1045\u20139 Google Search.","journal-title":"Anesthesiology"},{"issue":"1","key":"3150_CR2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s13539-012-0083-5","volume":"4","author":"L Santarpia","year":"2013","unstructured":"Santarpia L, Grandone I, Contaldo F, Pasanisi F. Butyrylcholinesterase as a prognostic marker: a review of the literature. J Cachexia Sarcopenia Muscle. 2013;4(1):31\u20139. https:\/\/doi.org\/10.1007\/s13539-012-0083-5.","journal-title":"J Cachexia Sarcopenia Muscle"},{"issue":"3","key":"3150_CR3","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1111\/j.1365-2044.1997.084-az0080.x","volume":"52","author":"L Davis","year":"1997","unstructured":"Davis L, Britten JJ, Morgan M. Cholinesterase its significance in anaesthetic practice. Anaesthesia. 1997;52(3):244\u201360.","journal-title":"Anaesthesia."},{"issue":"6 Suppl","key":"3150_CR4","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.4097\/kjae.2013.65.6S.S1","volume":"65","author":"S Lee","year":"2013","unstructured":"Lee S, Han JW, Kim ES. Butyrylcholinesterase deficiency identified by preoperative patient interview. Korean J Anesthesiol. 2013;65(6 Suppl):S1\u20133 Google Search.","journal-title":"Korean J Anesthesiol"},{"key":"3150_CR5","volume-title":"Clinical and Experimental Toxicology of Organophosphates and Carbamates","author":"AH Hall","year":"1992","unstructured":"Hall AH, Rumack BH. Incidence, presentation and therapeutic attitudes to ant cholinesterase poisoning in the USA. In: Ballantyne B, Marrs TC, editors. Clinical and Experimental Toxicology of Organophosphates and Carbamates. Oxford: Butterworth-Heinemann; 1992. Google Search."},{"key":"3150_CR6","unstructured":"Acetylcholine Neurotransmission (Section 1, Chapter 11) Neuroscience Online: An Electronic Textbook for the Neurosciences | Department of Neurobiology and Anatomy - The University of Texas Medical School at Houston"},{"key":"3150_CR7","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1097\/00000539-200005000-00036","volume":"90","author":"AF Kopman","year":"2000","unstructured":"Kopman AF, Klewicka MM, Neuman GG. An alternate method for estimating the dose-response relationships of neuromuscular blocking drugs. Anesth Analg. 2000;90:1191\u20137.","journal-title":"Anesth Analg"},{"issue":"8","key":"3150_CR8","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1034\/j.1399-6576.2002.460821.x","volume":"46","author":"EB Sener","year":"2002","unstructured":"Sener EB, Ustun E, Kocamanoglu S, Tur A. Prolonged apnea following succinylcholine administration in undiagnosed acute organophosphate poisoning. Acta Anaesthesiol Scand. 2002;46(8):1046\u20138.","journal-title":"Acta Anaesthesiol Scand"},{"issue":"2","key":"3150_CR9","doi-asserted-by":"publisher","first-page":"191","DOI":"10.4103\/0253-7176.92046","volume":"33","author":"TM Omprakash","year":"2011","unstructured":"Omprakash TM, Surender P. Prolonged apnea following modified electroconvulsive therapy with Suxamethonium. Indian J Psychol Med. 2011;33(2):191\u20133.","journal-title":"Indian J Psychol Med"},{"key":"3150_CR10","unstructured":"Taksande. A case report of prolonged apnea during electroconvulsive therapy in a patient with suicidal attempt by organophosphorus poison. [cited 2020 Jun 29]."},{"issue":"4","key":"3150_CR11","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1016\/j.genhosppsych.2009.11.001","volume":"32","author":"A Waghmare","year":"2010","unstructured":"Waghmare A, Kumar CN, Thirthalli J. Suxamethonium induced prolonged apnea in a patient receiving electroconvulsive therapy. Gen Hosp Psychiatry. 2010;32(4):447\u2013e1.","journal-title":"Gen Hosp Psychiatry"},{"issue":"7","key":"3150_CR12","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/01.fpc.0000197464.37211.77","volume":"16","author":"I Manoharan","year":"2006","unstructured":"Manoharan I, Wieseler S, Layer PG, Lockridge O, Boopathy R. Naturally occurring mutation Leu307Pro of human butyrylcholinesterase in the Vysya community of India. Pharmacogenet Genomics. 2006;16(7):461\u20138.","journal-title":"Pharmacogenet Genomics"},{"key":"3150_CR13","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1093\/bja\/35.9.528","volume":"35","author":"V Md","year":"1963","unstructured":"Md V. The Cholinesterases and their significance to the Anaesthetist using muscle relaxants. Br J Anaesth. 1963;35:528\u201334. https:\/\/doi.org\/10.1093\/bja\/35.9.528.","journal-title":"Br J Anaesth"},{"key":"3150_CR14","doi-asserted-by":"crossref","unstructured":"Mone, James G., and W. ERIC MATHIE. \u201cQualitative and quantitative defects of pseudocholinesterase activity.\u201d Anaesthesia 22.1 (1967): 55\u201368.","DOI":"10.1111\/j.1365-2044.1967.tb02695.x"}],"container-title":["BMC Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12888-021-03150-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12888-021-03150-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T13:08:56Z","timestamp":1615381736000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpsychiatry.biomedcentral.com\/articles\/10.1186\/s12888-021-03150-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,10]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["3150"],"URL":"https:\/\/doi.org\/10.1186\/s12888-021-03150-0","relation":{},"ISSN":["1471-244X"],"issn-type":[{"type":"electronic","value":"1471-244X"}],"subject":[],"published":{"date-parts":[[2021,3,10]]},"assertion":[{"value":"31 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 March 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 March 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Consent was taken.Ethics committee approval from UN Indian field hospital, level - III, Goma, DRC for Project No: 211\/14 was considered by the Ethics Committee on 26-May-2019 which met the requirements of the National Statement on Ethical Conduct in Human Research (2007) and was APPROVED on 5-June-2019.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The authors certify that they have obtained all appropriate patient consent forms in the written format, which can be made available to the journal. The patient has given her consent for her images and other clinical information to be reported in the journal. The patient understand that her name and initials will not be published and due efforts will be made to conceal their identity, but anonymity cannot be guaranteed.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Nil.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"148"}}